| Product Code: ETC13376458 | Publication Date: Apr 2025 | Updated Date: Aug 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
| Market Size (2025) | USD 4.6 Billion |
| Forecast Size (2032) | USD 6.8 Billion |
| CAGR | 4.30% |
| Base Year | 2025 |
| Forecast Period | 2026-2032 |
| Largest Region | North America |
| Fastest Growing Region | Asia |
| Largest Segment | Endovascular Stent Grafts |
| Fastest Growing Segment | Peripheral Stent Grafts |
| Leading Companies | Medtronic, Abbott Laboratories, Boston Scientific, Gore Medical, Terumo Corporation |

The Global Stent Grafts Market was estimated at USD 4.6 Billion in 2025 and is projected to reach USD 6.8 Billion by 2032, growing at a CAGR of 4.30% from 2026 to 2032.
Currently, the Global Stent Grafts Market is undergoing transformative changes, largely influenced by the rising prevalence of cardiovascular conditions. The market's structural evolution emphasizes a shift towards less invasive surgical procedures, spurred by both patient preference and clinical efficacy.
The growing population of elderly individuals and the corresponding increase in cardiovascular disease diagnoses make this market particularly relevant. As healthcare providers prioritize patient safety and recovery time, stent graft applications are expected to become increasingly integrated into treatment protocols.
This graph illustrates the annual growth rates of the Global Stent Grafts Market from 2022 to 2032, highlighting a steady upward trajectory and projected expansion over the forecast period.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate (%) | Major Drivers |
| 2022 | 4.83 | A competitive landscape shift among stent graft manufacturers enhances patient care options. |
| 2023 | 6.25 | Gaining FDA approvals for innovative stent grafts drives market confidence and investment. |
| 2024 | 5.49 | Increasing focus on sustainable healthcare practices influences stent graft production processes. |
| 2025 | 6.03 | As raw material costs for stent grafts stabilize, manufacturers can lower pricing strategies. |
| 2026 | 5 | In North America, growing M&A activity among stent graft firms accelerates product development. |
| 2027 | 4.15 | Healthcare providers adopt advanced diagnostic imaging technologies to improve stent graft outcomes. |
| 2028 | 7.63 | Expanding hospital infrastructure enables wider distribution of stent grafts to underserved areas. |
| 2029 | 7.19 | A shift toward telehealth platforms changes patient engagement with stent graft procedures. |
| 2030 | 5.15 | Wearable monitoring devices enhance patient adherence post-stent graft implantation. |
| 2031 | 3.49 | Medical distributors adapt their strategies to changing consumer preferences for stent grafts. |
| 2032 | 7.67 | Cardiovascular specialists demand more skilled professionals to optimize stent graft interventions. |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary research methodology, combining internal industry data, secondary research, and primary validation, updated periodically to reflect current market conditions. As markets evolve rapidly, figures for certain industries may vary slightly and are intended as informed estimates rather than absolute figures. For the most current market sizing, we recommend validating figures with a 6Wresearch analyst.
Below are some of the specific key takeaways from the market, including:
The Global Stent Grafts Market faces notable restrictions, primarily related to high procedural costs and stringent regulatory landscapes. In Europe, for instance, regulatory compliance costs can exceed $1 million for stent graft devices, posing a significant barrier to entry for smaller firms. For example, the specific guidelines outlined by the European Medicines Agency require rigorous clinical trials, which can delay product availability and inflate costs. As a result, many smaller companies are under pressure to secure funding and streamline R&D processes to remain competitive in this high-stakes market.
Three significant trends are reshaping the Global Stent Grafts Market. First, an evident shift toward minimally invasive procedures is driving clinical practices; hospitals are increasingly adopting stent graft solutions that require smaller incisions, resulting in shorter recovery times. For instance, Boston Scientific's latest stent design has seen a 30% reduction in complication rates since its launch in 2021, exemplifying clinical efficacy. Second, there is a marked trend toward biocompatible materials in stent design, which is improving patient outcomes and reducing the rates of complications. Third, AI integration in surgical planning tools is enhancing procedural accuracy; for example, Terumo Corporation recently unveiled a platform leveraging machine learning to optimize stent placement, marking a significant technological advancement. These operational shifts will continue to shape the market landscape well into the coming years.
Several lucrative opportunities lie ahead for stakeholders in the Global Stent Grafts Market. First, the development of bioresorbable stent grafts is gaining traction, with companies such as Abbott Laboratories investing over $200 million in research to bring these innovative products to market. This presents a unique revenue stream targeting younger populations with complex vascular conditions. Second, emerging markets like India and Brazil are increasingly modernizing their healthcare infrastructure, creating avenues for companies to establish a foothold in regions with previously unmet medical needs. For instance, Medtronic's collaborations with local hospitals aim to deliver stent graft solutions tailored to these markets. Third, there’s potential in the medical tourism sector, especially in Asia, where patients are seeking quality stent graft procedures at competitive costs, creating additional revenue channels for healthcare providers.
Endovascular Stent Grafts are the largest segment within the Global Stent Grafts Market, commanding an estimated ~60% share in 2025. This superiority results from their effectiveness in treating aortic aneurysms and various other vascular conditions, making them the preferred choice among clinicians. Meanwhile, the Peripheral Stent Grafts segment is anticipated to be the fastest-growing category, expected to achieve a CAGR of 5.5% from 2026 to 2032. The rising incidence of peripheral artery disease, coupled with improved stent design, is propelling this growth.
Aortic Aneurysm applications lead the Global Stent Grafts Market with an estimated share of ~50% in 2025, primarily due to the increasing prevalence of cardiovascular diseases associated with the aging population. Conversely, the fastest-growing application is projected to be Peripheral Artery Disease, with a CAGR of 6.2% from 2026 to 2032, driven by rising awareness and advancements in treatment options.
Metal Stents continue to hold a significant lead in the Global Stent Grafts Market, with an estimated ~70% share in 2025, due to their durability and historical efficacy in vascular applications. However, Polymer Stents are experiencing a surge, projected to demonstrate a CAGR of 6.0% from 2026 to 2032. Innovations in polymer materials are enhancing biocompatibility and reducing complications, making them increasingly attractive options for medical professionals.
Hospitals are the largest end-user segment in the Global Stent Grafts Market, holding a share of approximately ~75% in 2025, mainly due to their capacity for advanced surgical procedures and high patient volume. Meanwhile, Ambulatory Surgical Centers are projected to grow rapidly, with a CAGR of 5.2% from 2026 to 2032. The shift towards outpatient care models is fueling this growth, as more procedures become feasible outside traditional hospital settings.
The regulatory environment surrounding the Global Stent Grafts Market is dynamic, with various government initiatives aimed at enhancing patient access and safety. Increasing awareness and prioritization of cardiovascular health have led to targeted actions by several government entities.
The Global Stent Grafts Market is likely to experience transformative changes, particularly with a growing focus on bioresorbable technologies. Companies like Abbott Laboratories are spearheading initiatives, dedicating resources to develop innovative products aimed at younger demographics with specific vascular needs. This shift is expected to redefine treatment paradigms by promoting safer, more effective interventions that prioritize patient recovery and satisfaction. Anticipatory strategies around emerging applications will enhance competitiveness through 2032.
Recent developments in the Global Stent Grafts Market underscore the industry's commitment to innovation and expansion. These advancements reveal strategic movements aimed at strengthening market positions and enhancing product offerings.
The Global Stent Grafts Market is predominantly consolidated, featuring key players that dominate the landscape through unique technological strengths and comprehensive product portfolios. These leading companies, committed to research and development, have positioned themselves as frontrunners in advancing stent graft technologies.
| Leading Company | Core Strength | Strategic Focus |
|---|---|---|
| Medtronic | Leads in R&D investment and innovative stent designs | Enhancing patient outcomes through technology integration |
| Abbott Laboratories | Strong focus on biocompatible materials for stents | Development of bioresorbable stents for younger patients |
| Boston Scientific | Robust clinical trial network and market adaptability | Broadening applications in various vascular conditions |
| Gore Medical | Innovative product designs with a focus on safety | Addressing peripheral vascular diseases through new solutions |
| Terumo Corporation | Emerging leader in machine learning applications for stents | Expanding market reach and manufacturing in Asia |
As the market evolves, continued investment in technology and strategic partnerships will be essential for these key players to maintain their competitive edge and adapt to changing healthcare demands.
Global Stent Grafts Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Stent Grafts Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Stent Grafts Market Revenues & Volume, 2022 & 2032F |
3.3 Global Stent Grafts Market - Industry Life Cycle |
3.4 Global Stent Grafts Market - Porter's Five Forces |
3.5 Global Stent Grafts Market Revenues & Volume Share, By Regions, 2022 & 2032F |
3.6 Global Stent Grafts Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.7 Global Stent Grafts Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Global Stent Grafts Market Revenues & Volume Share, By Material Type, 2022 & 2032F |
3.9 Global Stent Grafts Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Global Stent Grafts Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Stent Grafts Market Trends |
6 Global Stent Grafts Market, 2022-2032 |
6.1 Global Stent Grafts Market, Revenues & Volume, By Product Type, 2022-2032 |
6.1.1 Overview & Analysis |
6.1.2 Global Stent Grafts Market, Revenues & Volume, By Endovascular Stent Grafts, 2022-2032 |
6.1.3 Global Stent Grafts Market, Revenues & Volume, By Peripheral Stent Grafts, 2022-2032 |
6.1.4 Global Stent Grafts Market, Revenues & Volume, By Coronary Stent Grafts, 2022-2032 |
6.1.5 Global Stent Grafts Market, Revenues & Volume, By Synthetic Stent Grafts, 2022-2032 |
6.2 Global Stent Grafts Market, Revenues & Volume, By Application, 2022-2032 |
6.2.1 Overview & Analysis |
6.2.2 Global Stent Grafts Market, Revenues & Volume, By Aortic Aneurysm, 2022-2032 |
6.2.3 Global Stent Grafts Market, Revenues & Volume, By Peripheral Artery Disease, 2022-2032 |
6.2.4 Global Stent Grafts Market, Revenues & Volume, By Coronary Artery Disease, 2022-2032 |
6.2.5 Global Stent Grafts Market, Revenues & Volume, By Trauma Repair, 2022-2032 |
6.3 Global Stent Grafts Market, Revenues & Volume, By Material Type, 2022-2032 |
6.3.1 Overview & Analysis |
6.3.2 Global Stent Grafts Market, Revenues & Volume, By Metal Stents, 2022-2032 |
6.3.3 Global Stent Grafts Market, Revenues & Volume, By Polymer Stents, 2022-2032 |
6.3.4 Global Stent Grafts Market, Revenues & Volume, By Hybrid Stents, 2022-2032 |
6.3.5 Global Stent Grafts Market, Revenues & Volume, By Bioabsorbable Stents, 2022-2032 |
6.4 Global Stent Grafts Market, Revenues & Volume, By End User, 2022-2032 |
6.4.1 Overview & Analysis |
6.4.2 Global Stent Grafts Market, Revenues & Volume, By Hospitals, 2022-2032 |
6.4.3 Global Stent Grafts Market, Revenues & Volume, By Ambulatory Surgical Centers, 2022-2032 |
6.4.4 Global Stent Grafts Market, Revenues & Volume, By Cardiac Centers, 2022-2032 |
6.4.5 Global Stent Grafts Market, Revenues & Volume, By Specialty Clinics, 2022-2032 |
7 North America Stent Grafts Market, Overview & Analysis |
7.1 North America Stent Grafts Market Revenues & Volume, 2022-2032 |
7.2 North America Stent Grafts Market, Revenues & Volume, By Countries, 2022-2032 |
7.2.1 United States (US) Stent Grafts Market, Revenues & Volume, 2022-2032 |
7.2.2 Canada Stent Grafts Market, Revenues & Volume, 2022-2032 |
7.2.3 Rest of North America Stent Grafts Market, Revenues & Volume, 2022-2032 |
7.3 North America Stent Grafts Market, Revenues & Volume, By Product Type, 2022-2032 |
7.4 North America Stent Grafts Market, Revenues & Volume, By Application, 2022-2032 |
7.5 North America Stent Grafts Market, Revenues & Volume, By Material Type, 2022-2032 |
7.6 North America Stent Grafts Market, Revenues & Volume, By End User, 2022-2032 |
8 Latin America (LATAM) Stent Grafts Market, Overview & Analysis |
8.1 Latin America (LATAM) Stent Grafts Market Revenues & Volume, 2022-2032 |
8.2 Latin America (LATAM) Stent Grafts Market, Revenues & Volume, By Countries, 2022-2032 |
8.2.1 Brazil Stent Grafts Market, Revenues & Volume, 2022-2032 |
8.2.2 Mexico Stent Grafts Market, Revenues & Volume, 2022-2032 |
8.2.3 Argentina Stent Grafts Market, Revenues & Volume, 2022-2032 |
8.2.4 Rest of LATAM Stent Grafts Market, Revenues & Volume, 2022-2032 |
8.3 Latin America (LATAM) Stent Grafts Market, Revenues & Volume, By Product Type, 2022-2032 |
8.4 Latin America (LATAM) Stent Grafts Market, Revenues & Volume, By Application, 2022-2032 |
8.5 Latin America (LATAM) Stent Grafts Market, Revenues & Volume, By Material Type, 2022-2032 |
8.6 Latin America (LATAM) Stent Grafts Market, Revenues & Volume, By End User, 2022-2032 |
9 Asia Stent Grafts Market, Overview & Analysis |
9.1 Asia Stent Grafts Market Revenues & Volume, 2022-2032 |
9.2 Asia Stent Grafts Market, Revenues & Volume, By Countries, 2022-2032 |
9.2.1 India Stent Grafts Market, Revenues & Volume, 2022-2032 |
9.2.2 China Stent Grafts Market, Revenues & Volume, 2022-2032 |
9.2.3 Japan Stent Grafts Market, Revenues & Volume, 2022-2032 |
9.2.4 Rest of Asia Stent Grafts Market, Revenues & Volume, 2022-2032 |
9.3 Asia Stent Grafts Market, Revenues & Volume, By Product Type, 2022-2032 |
9.4 Asia Stent Grafts Market, Revenues & Volume, By Application, 2022-2032 |
9.5 Asia Stent Grafts Market, Revenues & Volume, By Material Type, 2022-2032 |
9.6 Asia Stent Grafts Market, Revenues & Volume, By End User, 2022-2032 |
10 Africa Stent Grafts Market, Overview & Analysis |
10.1 Africa Stent Grafts Market Revenues & Volume, 2022-2032 |
10.2 Africa Stent Grafts Market, Revenues & Volume, By Countries, 2022-2032 |
10.2.1 South Africa Stent Grafts Market, Revenues & Volume, 2022-2032 |
10.2.2 Egypt Stent Grafts Market, Revenues & Volume, 2022-2032 |
10.2.3 Nigeria Stent Grafts Market, Revenues & Volume, 2022-2032 |
10.2.4 Rest of Africa Stent Grafts Market, Revenues & Volume, 2022-2032 |
10.3 Africa Stent Grafts Market, Revenues & Volume, By Product Type, 2022-2032 |
10.4 Africa Stent Grafts Market, Revenues & Volume, By Application, 2022-2032 |
10.5 Africa Stent Grafts Market, Revenues & Volume, By Material Type, 2022-2032 |
10.6 Africa Stent Grafts Market, Revenues & Volume, By End User, 2022-2032 |
11 Europe Stent Grafts Market, Overview & Analysis |
11.1 Europe Stent Grafts Market Revenues & Volume, 2022-2032 |
11.2 Europe Stent Grafts Market, Revenues & Volume, By Countries, 2022-2032 |
11.2.1 United Kingdom Stent Grafts Market, Revenues & Volume, 2022-2032 |
11.2.2 Germany Stent Grafts Market, Revenues & Volume, 2022-2032 |
11.2.3 France Stent Grafts Market, Revenues & Volume, 2022-2032 |
11.2.4 Rest of Europe Stent Grafts Market, Revenues & Volume, 2022-2032 |
11.3 Europe Stent Grafts Market, Revenues & Volume, By Product Type, 2022-2032 |
11.4 Europe Stent Grafts Market, Revenues & Volume, By Application, 2022-2032 |
11.5 Europe Stent Grafts Market, Revenues & Volume, By Material Type, 2022-2032 |
11.6 Europe Stent Grafts Market, Revenues & Volume, By End User, 2022-2032 |
12 Middle East Stent Grafts Market, Overview & Analysis |
12.1 Middle East Stent Grafts Market Revenues & Volume, 2022-2032 |
12.2 Middle East Stent Grafts Market, Revenues & Volume, By Countries, 2022-2032 |
12.2.1 Saudi Arabia Stent Grafts Market, Revenues & Volume, 2022-2032 |
12.2.2 UAE Stent Grafts Market, Revenues & Volume, 2022-2032 |
12.2.3 Turkey Stent Grafts Market, Revenues & Volume, 2022-2032 |
12.3 Middle East Stent Grafts Market, Revenues & Volume, By Product Type, 2022-2032 |
12.4 Middle East Stent Grafts Market, Revenues & Volume, By Application, 2022-2032 |
12.5 Middle East Stent Grafts Market, Revenues & Volume, By Material Type, 2022-2032 |
12.6 Middle East Stent Grafts Market, Revenues & Volume, By End User, 2022-2032 |
13 Global Stent Grafts Market Key Performance Indicators |
14 Global Stent Grafts Market - Export/Import By Countries Assessment |
15 Global Stent Grafts Market - Opportunity Assessment |
15.1 Global Stent Grafts Market Opportunity Assessment, By Countries, 2022 & 2032F |
15.2 Global Stent Grafts Market Opportunity Assessment, By Product Type, 2022 & 2032F |
15.3 Global Stent Grafts Market Opportunity Assessment, By Application, 2022 & 2032F |
15.4 Global Stent Grafts Market Opportunity Assessment, By Material Type, 2022 & 2032F |
15.5 Global Stent Grafts Market Opportunity Assessment, By End User, 2022 & 2032F |
16 Global Stent Grafts Market - Competitive Landscape |
16.1 Global Stent Grafts Market Revenue Share, By Companies, 2025 |
16.2 Global Stent Grafts Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here